{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8"],"submitter":["Zvulunov A"],"pubmed_abstract":["<h4>Background</h4>Mobile health apps can boost treatment adherence and support disease management at home. The Atopic App and web-based Atopic School patient education program offer a chance to enhance adherence to atopic dermatitis (AD) management.<h4>Objective</h4>We aim to evaluate the feasibility, acceptability, and preliminary efficacy of the Atopic App mobile health intervention in the managing of AD in children.<h4>Methods</h4>A randomized controlled study in children with AD divided participants into 3 groups: a control group (no app), an observational group with the app, and an interventional group with investigator supervision. Patients were examined at screening and follow-up visits 1 and 2 at 3-month intervals. Outcome measures included SCORAD (Scoring Atopic Dermatitis) for o"],"journal":["JMIR dermatology"],"pagination":["e60479"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11776342"],"repository":["biostudies-literature"],"pubmed_title":["Mobile Health App as an Auxiliary Tool in Management of Atopic Dermatitis in Children: Randomized Controlled Trial."],"pmcid":["PMC11776342"],"pubmed_authors":["Zvulunov A","Migacheva N","Lenevich S"],"additional_accession":[]},"is_claimable":false,"name":"Mobile Health App as an Auxiliary Tool in Management of Atopic Dermatitis in Children: Randomized Controlled Trial.","description":"<h4>Background</h4>Mobile health apps can boost treatment adherence and support disease management at home. The Atopic App and web-based Atopic School patient education program offer a chance to enhance adherence to atopic dermatitis (AD) management.<h4>Objective</h4>We aim to evaluate the feasibility, acceptability, and preliminary efficacy of the Atopic App mobile health intervention in the managing of AD in children.<h4>Methods</h4>A randomized controlled study in children with AD divided participants into 3 groups: a control group (no app), an observational group with the app, and an interventional group with investigator supervision. Patients were examined at screening and follow-up visits 1 and 2 at 3-month intervals. Outcome measures included SCORAD (Scoring Atopic Dermatitis) for o","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2026-06-01T22:08:58.46Z","creation":"2025-08-12T03:04:40.472Z"},"accession":"S-EPMC11776342","cross_references":{"pubmed":["39864440"],"doi":["10.2196/60479"]}}